Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma.

L. Shvayko (Kyiv, Ukraine)

Source: International Congress 2017 – Case reports and series
Session: Case reports and series
Session type: Thematic Poster
Number: 1234
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Shvayko (Kyiv, Ukraine). Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma.. 1234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015


Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour
Source: Eur Respir J 2007; 29: 117-126
Year: 2007



Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


Reduction of peak oxygen consumption in patients with non-small cell lung cancer treated with neoadjuvant chemotherapy
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Pulmonary toxicity during chemotherapy with etopiside and carboplatin
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Accelereated hyperfractionated radiotherapy with uneven crushing daily dose in chemoradiation treatment of inoperable non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Carcinomatous lymphangitis of a tracheal bifurcation in lung cancer: the role of neoadjuvant chemotherapy followed by surgery
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Single agent gemcitabine or docetaxel in the second-line therapy for patients with non-small cell lung cancer previously treated with platin-based chemotherapy
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013

Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Poor prognostic factors in advanced pulmonary adenocarcinoma patients receiving first-line gefitinib
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013

Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Consolidation maintenance oral vinorelbine following concurrent chemoradiation of intravenous vinorelbine and cisplatin in patients with unresectable stage III non-small cell lung cancer
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009



Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015

Surgery and multimodality treatment for malignant pleural mesothelioma
Source: Eur Respir Mon; 2009: 44: 407–418
Year: 2009